Department of Bioengineering and Therapeutic Sciences

Dynamic modeling of cancer signaling for precision medicine: a QBI/SBI Seminar with Dirk Fey

Wed Oct 20, 2021
Fey.
The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland.

Creating Healthy and Inclusive Spaces – Equity and Inclusion Speaker Series

Wed Oct 20, 2021
Eight people on a video call

Panelists and moderators in discussion. Top to bottom, left to right: Aashish Manglik, PhD; Nevan Krogan, PhD; B. Joseph Guglielmo, PharmD; Tejal Desai, PhD; Angelica Sandoval-Perez, PhD; Jason Sello, PhD; Michael Keiser, PhD; Willow Coyote-Maestas, PhD.

Faculty members shared their experiences and advice on creating healthy and inclusive spaces at the lab, department, and School levels.

Desai wins Chancellor Award for Advancement of Women

Tue Oct 19, 2021
Desai
Todd Dubnicoff

Tejal Desai, PhD

Honor recognizes outstanding commitment and service to the advancement of women

Stanford.Berkeley.UCSF Next Generation Faculty Symposium

Mon Oct 11, 2021
four keynote and special guest speakers.

Top to bottom: Erich Jarvis, PhD; Persis Drell, PhD; Catherine P. Koshland, PhD; and Dan Lowenstein, PhD.

About this event

Bay Area research team wins prize for working prototype of artificial kidney

Thu Sep 30, 2021

Kroetz named next chair of Department of Bioengineering and Therapeutic Sciences

Wed Sep 29, 2021
Scientist in a blue laboratory coat
Elisabeth Fall

Deanna Kroetz, PhD

Kroetz brings expertise in both science and pharmacy education to her new role as department chair.

The Kidney Project successfully tests a prototype bioartificial kidney

Thu Sep 9, 2021
two blue plates with tubes
The Kidney Project

The Kidney Project’s bioartificial kidney, which was successfully implanted in a preclinical model.

The Kidney Project earned a $650,000 award for a successful demonstration of its artificial kidney

Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-Science: a QBI online seminar with Peter Hotez

Thu Sep 2, 2021
Hotez.
The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series present Peter Hotez, PhD, Dean of the National School of Tropical Medicine and Professor of Pediatrics, Molecular Virology & Microbiology at Baylor College of Medicine, and Professor at Baylor University.

Data-driven drug dosing speeds tuberculosis treatment to four months

Mon Aug 30, 2021
bacterial cells
NIAID/NIH

Mycobacterium tuberculosis, the cause of tuberculosis

A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.

Science in the Time of Corona: Using Cryo-EM and collaboration to understand SARS-CoV-2 antibodies

Fri Aug 20, 2021
event poster
QBI TV presents Science in the Time of Corona, a live show where scientists discuss how COVID-19 has evolved science. Moderated by Robin Marks of the UCSF Office of Communications, the discussion will highlight recent research conducted by the QBI Coronavirus Research Group.

Pages